- Home
- FBIO
as 12-18-2024 10:37am EST
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | BAY HARBOR ISLANDS |
| Market Cap: | 39.4M | IPO Year: | N/A |
| Target Price: | $18.00 | AVG Volume (30 days): | 691.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.36 - $4.43 | Next Earning Date: | 11-14-2024 |
| Revenue: | $81,501,000 | Revenue Growth: | 31.51% |
| Revenue Growth (this year): | -29.84% | Revenue Growth (next year): | 134.70% |
Latest Fortress Biotech Inc. News
FBIO Breaking Stock News: Dive into FBIO Ticker-Specific Updates for Smart Investing
GlobeNewswire
5 days ago
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT™ (cosibelimab-ipdl)
Simply Wall St.
a month ago
Fortress Biotech Third Quarter 2024 Earnings: Misses Expectations
Associated Press Finance
a month ago
Fortress Biotech: Q3 Earnings Snapshot
GlobeNewswire
a month ago
Fortress Biotech Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
a month ago
Avenue Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
a month ago
Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
GlobeNewswire
a month ago
Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
a month ago
Mustang Bio Receives Positive Listing Determination from Nasdaq
Compare FBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FBIO Fortress Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.